This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción 38G
Sproutly Canada Inc. produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumables markets in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 2 riesgos adicionales
Competidores de Sproutly Canada Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.011 |
| 52 Week High | CA$0.037 |
| 52 Week Low | CA$0.0005 |
| Beta | 0.40 |
| 1 Month Change | 0% |
| 3 Month Change | 16.67% |
| 1 Year Change | -51.16% |
| 3 Year Change | -91.53% |
| 5 Year Change | n/a |
| Change since IPO | -97.50% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| 38G | DE Pharmaceuticals | Mercado DE | |
|---|---|---|---|
| 7D | 0% | -3.3% | -1.5% |
| 1Y | -51.2% | -30.8% | 0.9% |
Rentabilidad vs. Industria: 38G underperformed the German Pharmaceuticals industry which returned -14.1% over the past year.
Rentabilidad vs. Mercado: 38G underperformed the German Market which returned -22.2% over the past year.
Volatilidad de los precios
| 38G volatility | |
|---|---|
| 38G Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: 38G has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine 38G's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| n/a | n/a | Arup Sen | www.sproutly.ca |
Resumen de fundamentos de Sproutly Canada Inc.
| Estadísticas fundamentales de 38G | |
|---|---|
| Capitalización bursátil | €5.32m |
| Beneficios(TTM) | -€9.68m |
| Ingresos (TTM) | €374.75k |
14.3x
Ratio precio-ventas (PS)-0.5x
Ratio precio-beneficio (PE)¿Está 38G sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de 38G | |
|---|---|
| Ingresos | CA$533.55k |
| Coste de los ingresos | CA$774.88k |
| Beneficio bruto | -CA$241.33k |
| Otros gastos | CA$13.54m |
| Beneficios | -CA$13.79m |
Últimos beneficios comunicados
Nov 30, 2021
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.036 |
| Margen bruto | -45.23% |
| Margen de beneficio neto | -2,583.86% |
| Ratio deuda/patrimonio | -141.1% |
¿Cómo se ha desempeñado 38G a largo plazo?
Ver rendimiento histórico y comparativa